Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Harding

Showing results (901-910 of 946) with videos related to

Pageof 95
Sort By:
Space Science Reviews|July 20, 2023
The Ionospheric Connection Explorer - Prime Mission ReviewThomas J Immel, Scott L England, Brian J Harding, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 17, 2018
Phase III randomized study of second line ADI-PEG 20 plus best supportive care versus placebo plus best supportive care in patients with advanced hepatocellular carcinomaG K Abou-Alfa, S Qin, B-Y Ryoo, et al.
Nucleic Acids Research|April 30, 2025
PRMT5 promotes full-length HTT expression by repressing multiple proximal intronic polyadenylation sitesManisha Yadav, Mona A AlQazzaz, Felipe E Ciamponi, et al.
Journal of Medicinal Chemistry|October 6, 2025
Enabling Open Machine Learning of Deoxyribonucleic Acid-Encoded Library Selections to Accelerate the Discovery of Small Molecule Protein BindersJames Wellnitz, Shabbir Ahmad, Nabin Bagale, et al.
JAMA Oncology|September 6, 2019
Assessment of Treatment With Sorafenib Plus Doxorubicin vs Sorafenib Alone in Patients With Advanced Hepatocellular Carcinoma: Phase 3 CALGB 80802 Randomized Clinical TrialGhassan K Abou-Alfa, Qian Shi, Jennifer J Knox, et al.
Nature Communications|February 6, 2023
Antitumour activity of neratinib in patients with HER2-mutant advanced biliary tract cancersJames J Harding, Sarina A Piha-Paul, Ronak H Shah, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 14, 2026
Clinical and Psychological Outcomes After Monoclonal Gammopathy Screening: A Population-Based Screening Study and Subsequent Randomized Trial of Follow-UpSæmundur Rögnvaldsson, Sigrún Thorsteinsdóttir, Elias Eythorsson, et al.
Annals of Surgical Oncology|January 28, 2025
ASO Visual Abstract: Adjuvant Cytotoxic Chemotherapy May Not Be Associated with a Survival Advantage for Resected Intrahepatic CholangiocarcinomaJeremy Sharib, Kristen E Rhodin, Annie Liu, et al.
Annals of Surgical Oncology|January 18, 2025
Adjuvant Cytotoxic Chemotherapy may not be Associated with a Survival Advantage for Resected Intrahepatic CholangiocarcinomaJeremy Sharib, Kristen E Rhodin, Annie Liu, et al.
Faraday Discussions|August 12, 2024
Scattering at condensed-phase surfaces: general discussionDaniel J Auerbach, Dmitri Babikov, Alexander Butler, et al.
Pageof 95

Showing results (901-910 of 946) with videos related to

Sort By:
Pageof 95
Space Science Reviews|July 20, 2023
The Ionospheric Connection Explorer - Prime Mission ReviewThomas J Immel, Scott L England, Brian J Harding, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 17, 2018
Phase III randomized study of second line ADI-PEG 20 plus best supportive care versus placebo plus best supportive care in patients with advanced hepatocellular carcinomaG K Abou-Alfa, S Qin, B-Y Ryoo, et al.
Nucleic Acids Research|April 30, 2025
PRMT5 promotes full-length HTT expression by repressing multiple proximal intronic polyadenylation sitesManisha Yadav, Mona A AlQazzaz, Felipe E Ciamponi, et al.
Journal of Medicinal Chemistry|October 6, 2025
Enabling Open Machine Learning of Deoxyribonucleic Acid-Encoded Library Selections to Accelerate the Discovery of Small Molecule Protein BindersJames Wellnitz, Shabbir Ahmad, Nabin Bagale, et al.
JAMA Oncology|September 6, 2019
Assessment of Treatment With Sorafenib Plus Doxorubicin vs Sorafenib Alone in Patients With Advanced Hepatocellular Carcinoma: Phase 3 CALGB 80802 Randomized Clinical TrialGhassan K Abou-Alfa, Qian Shi, Jennifer J Knox, et al.
Nature Communications|February 6, 2023
Antitumour activity of neratinib in patients with HER2-mutant advanced biliary tract cancersJames J Harding, Sarina A Piha-Paul, Ronak H Shah, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 14, 2026
Clinical and Psychological Outcomes After Monoclonal Gammopathy Screening: A Population-Based Screening Study and Subsequent Randomized Trial of Follow-UpSæmundur Rögnvaldsson, Sigrún Thorsteinsdóttir, Elias Eythorsson, et al.
Annals of Surgical Oncology|January 28, 2025
ASO Visual Abstract: Adjuvant Cytotoxic Chemotherapy May Not Be Associated with a Survival Advantage for Resected Intrahepatic CholangiocarcinomaJeremy Sharib, Kristen E Rhodin, Annie Liu, et al.
Annals of Surgical Oncology|January 18, 2025
Adjuvant Cytotoxic Chemotherapy may not be Associated with a Survival Advantage for Resected Intrahepatic CholangiocarcinomaJeremy Sharib, Kristen E Rhodin, Annie Liu, et al.
Faraday Discussions|August 12, 2024
Scattering at condensed-phase surfaces: general discussionDaniel J Auerbach, Dmitri Babikov, Alexander Butler, et al.
Pageof 95